Estimated risk of clopidogrel resistance in patients with at least one of the following risk factors: CYP2C19*2, CYP2C19*3, smoking, diabetes mellitus, increase in platelet count adjusted for age and sex.

*Estimated OR for each risk factor category compared to men with no CYP2C19 mutation (wild type), with average age (66.25 year-old), average platelet count (255,900 platelets/mm3), who do not smoke and do not have diabetes. Platelet variable is calculated per ×1,000 platelet increased. Log odds for clopidogrel resistance were calculated using multivariate logistic regression as a function of CYP2C19*2+CYP2C19*3+Smoking+Diabetic Status+increased Platelet Count.†Risk is statistically significant when compared to the reference genotype at p-valueEstimated risk of clopidogrel resistance in patients with at least one of the following risk factors: CYP2C19*2, CYP2C19*3, smoking, diabetes mellitus, increase in platelet count adjusted for age and sex.